Quininib

Overview

Quininib is a cysteinyl leukotriene 1 and 2 receptor antagonist with IC 50 s of 1.2 and 52 μM for CysLT 1 R and CysLT 2 R , respectively. Quininib is a potent inhibitor of developmental angiogenesis in the zebrafish eye. Quininib can be used for the research of ocular neovascular pathologies and may complement current anti-VEGF biological agents.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Leukotriene Receptor

Product Information

• Catalog No.: HY-119442
• CAS No.: 143816-42-6
• Molecular Formula: C17H13NO
• Molecular Weight: 247.29
• Purity: 98.1%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source